Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3419642rdf:typepubmed:Citationlld:pubmed
pubmed-article:3419642lifeskim:mentionsumls-concept:C0006644lld:lifeskim
pubmed-article:3419642lifeskim:mentionsumls-concept:C0007450lld:lifeskim
pubmed-article:3419642lifeskim:mentionsumls-concept:C0521119lld:lifeskim
pubmed-article:3419642lifeskim:mentionsumls-concept:C0001625lld:lifeskim
pubmed-article:3419642lifeskim:mentionsumls-concept:C0001041lld:lifeskim
pubmed-article:3419642lifeskim:mentionsumls-concept:C0178719lld:lifeskim
pubmed-article:3419642lifeskim:mentionsumls-concept:C0332197lld:lifeskim
pubmed-article:3419642lifeskim:mentionsumls-concept:C1325901lld:lifeskim
pubmed-article:3419642lifeskim:mentionsumls-concept:C1444748lld:lifeskim
pubmed-article:3419642lifeskim:mentionsumls-concept:C0231491lld:lifeskim
pubmed-article:3419642lifeskim:mentionsumls-concept:C0596235lld:lifeskim
pubmed-article:3419642lifeskim:mentionsumls-concept:C1549542lld:lifeskim
pubmed-article:3419642lifeskim:mentionsumls-concept:C1533157lld:lifeskim
pubmed-article:3419642lifeskim:mentionsumls-concept:C0076760lld:lifeskim
pubmed-article:3419642pubmed:issue3lld:pubmed
pubmed-article:3419642pubmed:dateCreated1988-10-20lld:pubmed
pubmed-article:3419642pubmed:abstractTextUnlike acetylcholine, caffeine was much more effective in releasing catecholamine in the absence of extracellular Ca2+ than in its presence in perfused cat adrenal glands. The intracellular Ca2+ antagonist, TMB-8 (10(-4) M), inhibited reversibly the catecholamine secretion evoked by caffeine (40 mM) and that induced by acetylcholine (10(-4) M) in the presence of hexamethonium (10(-3) M) during perfusion with Ca2+-free Locke solution containing EGTA (10(-5) M). These results support our view that muscarinic receptor activation causes catecholamine secretion by mobilizing Ca2+ from an intracellular pool just as caffeine does.lld:pubmed
pubmed-article:3419642pubmed:languageenglld:pubmed
pubmed-article:3419642pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3419642pubmed:citationSubsetIMlld:pubmed
pubmed-article:3419642pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3419642pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3419642pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3419642pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3419642pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3419642pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3419642pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3419642pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3419642pubmed:statusMEDLINElld:pubmed
pubmed-article:3419642pubmed:monthAuglld:pubmed
pubmed-article:3419642pubmed:issn0304-3940lld:pubmed
pubmed-article:3419642pubmed:authorpubmed-author:YamadaYYlld:pubmed
pubmed-article:3419642pubmed:authorpubmed-author:TeraokaHHlld:pubmed
pubmed-article:3419642pubmed:authorpubmed-author:NakazatoYYlld:pubmed
pubmed-article:3419642pubmed:authorpubmed-author:OhgaAAlld:pubmed
pubmed-article:3419642pubmed:issnTypePrintlld:pubmed
pubmed-article:3419642pubmed:day1lld:pubmed
pubmed-article:3419642pubmed:volume90lld:pubmed
pubmed-article:3419642pubmed:ownerNLMlld:pubmed
pubmed-article:3419642pubmed:authorsCompleteYlld:pubmed
pubmed-article:3419642pubmed:pagination338-42lld:pubmed
pubmed-article:3419642pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:3419642pubmed:meshHeadingpubmed-meshheading:3419642-...lld:pubmed
pubmed-article:3419642pubmed:meshHeadingpubmed-meshheading:3419642-...lld:pubmed
pubmed-article:3419642pubmed:meshHeadingpubmed-meshheading:3419642-...lld:pubmed
pubmed-article:3419642pubmed:meshHeadingpubmed-meshheading:3419642-...lld:pubmed
pubmed-article:3419642pubmed:meshHeadingpubmed-meshheading:3419642-...lld:pubmed
pubmed-article:3419642pubmed:meshHeadingpubmed-meshheading:3419642-...lld:pubmed
pubmed-article:3419642pubmed:meshHeadingpubmed-meshheading:3419642-...lld:pubmed
pubmed-article:3419642pubmed:meshHeadingpubmed-meshheading:3419642-...lld:pubmed
pubmed-article:3419642pubmed:meshHeadingpubmed-meshheading:3419642-...lld:pubmed
pubmed-article:3419642pubmed:meshHeadingpubmed-meshheading:3419642-...lld:pubmed
pubmed-article:3419642pubmed:meshHeadingpubmed-meshheading:3419642-...lld:pubmed
pubmed-article:3419642pubmed:meshHeadingpubmed-meshheading:3419642-...lld:pubmed
pubmed-article:3419642pubmed:year1988lld:pubmed
pubmed-article:3419642pubmed:articleTitleIntracellular Ca2+ antagonist TMB-8 blocks catecholamine secretion evoked by caffeine and acetylcholine from perfused cat adrenal glands in the absence of extracellular Ca2+.lld:pubmed
pubmed-article:3419642pubmed:affiliationDepartment of Pharmacology, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.lld:pubmed
pubmed-article:3419642pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3419642pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:3419642pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3419642lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3419642lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3419642lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3419642lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3419642lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3419642lld:pubmed